• Home
  • Submit Paper
  • Check Paper Status
  • Download Certificate/Paper
  • FAQs
  • Feedback
  • Contact Us
Email: ijraset@gmail.com
IJRASET Logo
Journal Statistics & Approval Details
Recent Published Paper
Our Author's Feedback
 •  ISRA Impact Factor 7.894       •  SJIF Impact Factor: 7.538       •  Hard Copy of Certificates to All Authors       •  DOI by Crossref for all Published Papers       •  Soft Copy of Certificates- Within 04 Hours       •  Authors helpline No: +91-8813907089(Whatsapp)       •  No Publication Fee for Paper Submission       •  Hard Copy of Certificates to all Authors       •  UGC Approved Journal: IJRASET- Click here to Check     
  • About Us
    • About Us
    • Aim & Scope
  • Editorial Board
  • Impact Factor
  • Call For Papers
    • Submit Paper Online
    • Current Issue
    • Special Issue
  • For Authors
    • Instructions for Authors
    • Submit Paper
    • Download Certificates
    • Check Paper Status
    • Paper Format
    • Copyright Form
    • Membership
    • Peer Review
  • Past Issue
    • Monthly Issue
    • Special Issue
  • Pay Fee
    • Indian Authors
    • International Authors
  • Topics
ISSN: 2321-9653
Estd : 2013
IJRASET - Logo
  • Home
  • About Us
    • About Us
    • Aim & Scope
  • Editorial Board
  • Impact Factor
  • Call For Papers
    • Submit Paper Online
    • Current Issue
    • Special Issue
  • For Authors
    • Instructions for Authors
    • Submit Paper
    • Download Certificates
    • Check Paper Status
    • Paper Format
    • Copyright Form
    • Membership
    • Peer Review
  • Past Issue
    • Monthly Issue
    • Special Issue
  • Pay Fee
    • Indian Authors
    • International Authors
  • Topics

Ijraset Journal For Research in Applied Science and Engineering Technology

  • Home / Ijraset
  • On This Page
  • Abstract
  • Introduction
  • Conclusion
  • References
  • Copyright

Formulation and Evaluation of review on epilepsy and its management

Authors: Vikas Govind Kotkar , Prof. Latif Bagwan , Dr. L. D. Hingane

DOI Link: https://doi.org/10.22214/ijraset.2022.40688

Certificate: View Certificate

Abstract

In this project work we speak about different types of epilepsy. Epilepsy is 4th most common neurological disorder affecting 65 million peoples worldwide, according to epilepsy foundation of America, he found that approximately 45000 peoples are dead due to epilepsy. It is categorized into two main types i:e partial seizure( affecting small portion of brain) generalized seizures( covering all portion of brain). Several etiological factor responsible for causing epilepsy such genetic, CNS infection, metabolic disorders, miscellaneous. Epilepsy is caused due to imbalance between glutamate and GABA neurotransmitters. Abnormal jerking movement, confusion, fatigue, repetitive blinking are some common symptoms of epilepsy. While diagnostic test such as EEG, CT scan, PET scan, MRI and other treatment such ketogenic diet, vagus nerve stimulation, help to many people of all age who live with epilepsy. Today’s several antiepileptic drugs are available such as phenytoin, carbamazepine, ethosuximide, phenobarbital, may help to treat all types of epileptic seizures. So, there is need to continue research on it to treat all epileptic problems worldwide.

Introduction

I. INTRODUCTION

Epilepsy is a chronic disorder of the brain that affects people worldwide. Epilepsy is a chronic noncommunicable disorder of the brain hthat affects people of all ages.

It is characterized by recurrent seizures, which are brief episodes of involuntary movement that may involve a part of the body (partial) or the entire body (generalized), and are sometimes accompanied by loss of consciousness. There are over 2.5 million people diagnosed with epilepsy every year.

Epilepsy is one of 4th most common serious neurological disorder affecting about 65 million people globally. It affects 1% of the population by age 20 and 3% of the population by age 75. Nearly 80% of the people with epilepsy live in low and middle-income countries.

According to Epilepsy Foundation of America,  he  found  that  approximately 45,000 peoples are dead due to epilepsy. The estimated proportion is between 4 to 10 people /1000 is suffering from epilepsy.

During the 20th century, the invention of EEG, the advance in neurosurgery, the discovery of antiepileptic drugs, and the    delineation of underlying pathophysiological mechanisms, were the most significant advances in the field of research in epilepsy . Now a days different antiepileptic drugs are available to treat seizure.

II. DEFINITION

A. Epilepsy is a disease due to central nervous system disorder which is characterized by seizures and convulsion or other abnormal body movements with loss of consciousness.

B. A seizure is defined by release of excessive and uncontrolled electrical activity in the brain. OR it is hyperexcitation of neurones in the brain leading to altered behaviour with or without violent motor activity.

C. Depending on the type of seizure, this can cause changes in sensation and feeling awareness and consciousness behaviour or movement

III. TYPES OF EPILEPSY/ SEIZURES

Classification of seizures are as either focal or generalized, based on how the abnormal brain activity begins.

A. Generalized Seizures

  1. Tonic-clonic seizures/ Convulsive seizures
  2. Absence seizures
  3. Tonic seizures
  4. Clonic seizures
  5. Atonic seizures
  6. Myoclonic seizures

B. Focal Seizures
Focal seizures (previously called partial seizures) start in one part of the brain and affect the part of the body controlled by that part of the brain or generally produced in a small area of the brain (fig no1). The symptoms the person experiences will depend on the function that the focal point is associated with or controls. Depending on where they start and which parts of the brain they involve, focal seizures may or may not alter consciousness or awareness , they can classified into two types.

  1. Simple Focal Seizures: These seizures do not result in loss of consciousness. They may alter emotion or change the way things look, smell, feel, taste or sound. They may also result in involuntary jerking of the body parts,such as an arms or legs, and spontaneous sensory symptoms such as tingling, dizziness, and flashing lights.
  2. Dyscognitive Focal Seizures: These seizure alter consciousness or awareness and may cause to lose awareness for a longer period of time. Dyscognitive focal seizures often result  in  starting  and  purposeless  movements  such  as  hand  rubbing, chewing, swallowing, or walking in circles.

C. Generalized Seizures

Seizures that appear to involve all areas of the brain are called generalized seizures. Generalized epilepsy, also known as primary generalized epilepsy or idiopathic epilepsy, is a form of epilepsy characterized  by generalised seizures with no apparent cause

  • Bite your cheek or  tongue
  • Lick Your  Jaw
  • lose control of your bladder or bowels
  • Turn Blue in the face

Many generalized seizures start and spread so quickly it is impossible to identify the source. If the source of a seizure is unidentifiable, surgery is not available as a treatment option.

Generalized  seizures  follow  a  basic  pattern.  First,  your  muscles  stiffen  and become rigid. Then, you experience violent muscle contractions in which the muscles  move  in  quick,  random    spasms.

You lose consciousness, or black out, so that you’re no longer aware of what’s happening. The different types of generalized seizures are:

  1. Tonic-clonic Seizures: Tonic    means    stiffening,    and    clonic    means    rhythmical    jerking Tonic–clonic seizures (formerly known as grand mal seizures) are a type of generalized seizure that affects the entire brain. A tonic-clonic seizure usually begins on both sides of the brain, but can start in one side and spread to the whole brain.
  2. Absence Seizures: Most commonly seen I children’s. Absence seizures are   characterized   by   a   brief   loss   of   awareness,   impairment   of consciousness,  blank  stare,  brief  upward  rotation  of  eyes.  These  type seizures last from few second to half of minutes.
  3. Tonic Seizures: These are the type of generalized seizures which causes stiffening of muscles. These seizure usually affects the muscles of arms and legs and may cause to fall to the ground. These types of seizures usually last 1 to 3 minutes and take longer for a person to recover.
  4. Clonic Seizures: Clonic seizures are associated with rhythmic, jerking muscles movements. These seizures usually affects the neck,face, and legs.
  5. Atonic Seizures: These are the type of generalized seizures which causes a loss of muscle control or tone, which may result in suddenly collapse or fall dow. Atonic seizures can be begin in one area or side of the brain (focal onset) or both sides of the brain (generalized onset). These seizures typically last less than 15 second
  6. Myoclonic Seizure: These are the type of generalized seizures usually appear as sudden brief jerks or twitches of arm and legs. During a myoclonic seizure, the person is usually awake and able to think clearly. Myoclonic twitches or jerks usually  are  caused  by  sudden  muscle  contractions,  called  positive myoclonus, or by muscle relaxation, called negative myoclonus.

IV. ETIOLOGY / CAUSES
Many times the seizure are idiopathic in nature where exact cause6is not found. It may vary in peoples. Some people with no clear cause of epilepsy, but  may have a some following causes which are responsible for epilepsy.

V. PATHOGENESIS OF EPILEPSY

VI. PATHOGENESIS OF EPILEPSY
saCurrently, there is no universally accepted definition for epileptogenesis. The term epileptogenesis is defined as a process that leads to the occurrence of the first spontaneous seizure and recurring epileptiform events after the brain insult. OR Epileptogenesis is the process by which the previously normal brain is functionally altered and biased towards the generation of the abnormal electrical activity that subserves chronic seizures. Latency period refers to seizure-free or pre-epileptic periods between the brain insult and the occurrence of the first spontaneous seizure.

Fig 4:- Excitatory and inhibitory neurotransmitter involved in Pathogensis of epilepsy by binding to their specific receptor.

VII. SIGN AND SYMPTOMS

Following signs and symptoms are observed, if patients suffering from epilepsy.

  1. Loss of consciousness or awareness
  2. Uncontrollable/ involuntary jerking movements of arms and legs
  3. Visual hallucination
  4. Temporary confusion
  5. Alteration to sense of taste, smell, slight, hearing, and touch
  6. Performing repetitive movements
  7. Speech arrest, vocalizations
  8. Shaking
  9. Loss of bladder or bowel control
  10. Muscle stiffness, stiffening of body
  11. Episodes of staring
  12. Illusions
  13. Pupillary dilation/ eye rolling
  14. Repetitive movements of lip smacking and blinking
  15. Sometimes person goes in dreamy state
  16. Unusual fatigue
  17. Headache, nausea, vomiting
  18. Rapid heartbeats
  19. Sweating, excessive salivation
  20. Muscle spasms.
  21. Repetitive blinking of eyelids
  22. Altered mood

Table no 2:-Different epileptic seizures shows different sign and symptoms, they classified as following.

 

Sr.No

 

Type

 

Symptoms

A

 

Partial/ focal seizures

Involuntary         movement,                                unpleasant smell,taste,stiffening of limbs, altered emotion, nausea,seizure less than 2 min

 

a

Simple partial seizures

Change in way of things,odd sound,smell,taste, dizziness,  rising  feeling  in  tummy,involuntary movements of body parts such as arms & legs, flashing lights.

 

 

b

 

Complex                      partial seizures

 

Loss   of   consciousness,   picking   at   cloths, smacking  your  lips,    hand  rubbing,  chewing, swallowing, walking in circles

 

 

 

B

 

 

 

Generalized seizures

 

Loss    of    consciousness    or    awareness, involuntary jerking movements of arms and legs,   stiffening   of   body   muscles,   altered smell,taste,sound,  seizures  last  less  than  3 min.

a

Tonic-clonic seizures

Stiffening or rhythmical jerking movements of arms  and  legs,  shaking,  increase  heartbeats, loss  of  consciousness,  biting  tongue,  difficult in  breathing,  loss  of  bladder  control,lips  may turn blue, seizures at least 1-3 min.

 

b

 

Absence seizures

Blank  stare,  brief  loss  of  consciousness  or awareness, repetitive blinking, seizures at least

 

 

few sec to half of min.

 

c

 

Tonic seizures

 

Stiffening of muscles may cause to fall down, seizures at least 1-3 min.

 

d

 

Clonic seizures

 

Mainly affect on neck, face or legs.

 

 

e

 

 

Atonic seizures

 

Loss of muscle control or tone, results collapse or fall down, droop attack, seizures less than 15 sec.

 

f

 

Myoclonic seizures

 

Sudden brief jerks or twitches of arms and legs, muscles contraction.

VIII. DIAGNOSIS OF EPILEPSY

Epilepsy can be diagnosed by performing different test , they are given below. Your doctor may order several tests to diagnose epilepsy and determine the cause of seizures, they are given below

  1. Neurological examination
  2. Electroencephalogram (EEG) test
  3. Computerized axial tomography (CT scan CAT scan)
  4. Magnetic resonance imaging (MRI scan)
  5. Functional magnetic resonance imaging (fMRI scan)
  6. Positron emission tomography (PET scan)
  7. Complete blood count (CBC) test
  8. Chemistry panel
  9. Spinal tap test
  10. Single photo emission computerized tomography (SPECT scan)
  11. Magnetic resonance spectroscopy (MRS scan)

IX. COMPLICATIONS

Epileptic seizures create many complications, sometimes it is dangerous to human beings, they are given below.

A. Injuries and Accidents

  1. Injuries From Falls: Because many people with seizures fall, injuries are common. Although such injuries are usually minor, people with epilepsy have a higher incidence of fractures than those without the disorder. Patients who take the drug phenytoin have an even higher risk, since the drug can cause osteoporosis.
  2. Household Accidents: Household environments, such as the kitchen and bathroom can be dangerous places for children with epilepsy. Parents should take precautions to prevent burning accidents from stoves and other heat sources. Children with epilepsy should never be left alone when bathing.
  3. Driving and the Risk for Accidents: Being unable to drive is an extremely distressing and severe component of epilepsy. Drivers with well- controlled epilepsy are not at a high or unacceptable risk for automobile accidents. Uncontrolled epilepsy, however, poses a high risk. Needless to say, seizures can be very dangerous if they occur while a person is driving and result in injuries to the patient or others.
  4. Accidents while Swimming: Swimming poses another danger for people with epilepsy, particularly those with tonic seizures, which can cause the diaphragm to expel air quite suddenly. People with epilepsy who swim should avoid deep and cloudy water (a clear swimming pool is best), and always   swim   with   a   knowledgeable,   competent,   and   experienced companion or have a lifeguard on site.

B. Status epilepticus:- (7)

Status epilepticus is a medical emergency in which seizures recur without the patient regaining consciousness between events. This condition can develop in any type of seizure but is most common in tonic-clonic seizures. Status epilepticus may cause brain damage or cognitive dysfunction and may be fatal. Subsequent  seizures  become  briefer,  more  localized,  and may  be  reduced to myoclonic activity.

C. Sudden Unexplained Death in Epilepsy (SUDEP)

Sudden unexplained death in epilepsy (SUDEP) occurs in a small percentage of persons  with  epilepsy.  For  reasons  that  are  poorly  understood,  an  otherwise healthy person with epilepsy can die suddenly. While this also happens within the general population, persons with symptomatic epilepsy have a much greater risk. Autopsies have not uncovered a physical cause of SUDEP. It is possible that pulmonary   edema   (fluid   build-up   in   the   lungs),   suffocation,   or   cardiac arrhythmias (irregular heartbeat) may be responsible. Some people appear to be at a higher risk than others, such as young adults with generalized tonic-clonic seizures that are not fully controlled with medication and those who abuse alcohol and illicit drugs. Patients using two or more anticonvulsants may be at increased risk for SUDEP.

D. Effect of epilepsy on Children’s

  1. Long-term General Effects: In general, the long-term effects of seizures vary widely depending on the seizure's cause. The long-term outlook for children with idiopathic epilepsy (epilepsy of unknown causes) is very favorable. Children whose epilepsy is a result of a specific condition (for example, a head injury or neurologic disorder) have higher mortality rates than the normal population, but their lower survival rates are most often due to the underlying condition, not the epilepsy itself.
  2. Effect on Memory and Learning: The studies on the effects of seizures on memory and learning vary widely and depend on many factors. In general, the earlier a child has seizures and the more extensive the area of the brain affected, the poorer the outcome. Children with seizures that are not well-controlled are at higher risk for intellectual decline.
  3. Social and Behavioral Consequences: Learning and language problems, and  emotional  and  behavioral  disorders,  can  occur  in  some  children. Whether these problems are caused by the seizure disorder and anti- seizure medications or are simply part of the seizure disorder remains unclear.

E. Effect of Epilepsy in Adults

  1. Psychological Health: Many adults with epilepsy show signs of depression. People with epilepsy have a high risk for suicide, particularly in the first 6 months following diagnosis. The risk for suicide is highest among people who have epilepsy and an accompanying psychiatric condition such as depression, anxiety disorder, schizophrenia, or chronic alcohol  use.  Antiepileptic  drugs  (such  as  carbamazepine,  gabapentin, topiramate, valproate, and many others) can increase the risk of suicidal thoughts and behavior.
  2. Overall Health: Patients with epilepsy often describe their overall health as "fair" or "poor," compared to those who do not have epilepsy. People with epilepsy also report a higher frequency of pain, depression, anxiety, and sleep problems. In fact, their overall health state is comparable to people with other chronic diseases, including arthritis, heart problems, diabetes, and cancer. Treatments can cause considerable physical effects, such as osteoporosis and weight changes.

F. Effect On Sexual And Reproductive Health

  1. Effects on Sexual Function: Some patients with epilepsy experience sexual  disturbances,  including  erectile  dysfunction.  Causes  of  these problems may be emotional, medication induced, or a result of changes in hormone levels.
  2. Effects  on  Reproductive  Health: A  woman’s  hormonal  fluctuation  can affect the course of her seizures. Estrogen appears to increase seizure activity, and progesterone reduces it. Antiseizure medications may reduce the effectiveness of oral contraceptives. Epilepsy can pose risks both to a pregnant woman and her fetus. Some types of anti-epileptic drugs should not be taken during the first trimester as they can cause birth defects. Women with epilepsy who are thinking of becoming pregnant should talk to their doctors in advance to plan changes in their medication regimen. Women should learn about the risks associated with epilepsy and pregnancy, and precautions that can be taken to reduce them.

G. Effects of epilepsy on Pregnant Women

If  the  pregnant  women  suffering  from  tonic-clonic  seizure,  there  is  a temporary interruption of breathing; although this interruption rarely affects the mother, it can lead to oxygen deprivation in your baby. Additionally your baby’s heart rate can slow for as long as 30 minutes after a tonic-clonic seizure. This form of seizure also increases the risk of trauma to the baby. Tonic-clonic seizures present the greatest risk during the last trimester, when the baby’s brain is larger and needs more oxygen. Epilepsy can  affect  pregnancy in  a  variety  of ways.                                                                                      

If seizures occur during pregnancy, a number of complications can occur affecting the baby including:

  1. Fetal heart rate deceleration
  2. Fetal injury
  3. Premature separation of the placenta from the uterus
  4. Miscarriage due to trauma experienced during seizures
  5. Preterm labor
  6. Premature birth

H. Anticonvulsant drugs

Epileptic women have a 4-6 % chance of having a baby born with a birth defect as a result of taking anticonvulsant drugs. Some are  mild  defects  such  as  small  fingers  and  toenails.  However,  there  are more major birth defects such as spinal bifida, cleft lip, neural tube defects,  and  heart  abnormalities.  You  should  consult  your  doctor  about your anticonvulsant medication when trying to become pregnant. They may recommend changing your medication or lowering the dosage of your current medication.

X. NON-PHARMACOLOGICAL TREATMENT

Different non pharmacological treatment available to control epileptic seizures or also treat them.

A. Ketogenic Diet

The  ketogenic  diet  is  a  special  high-fat,  low-carbohydrate  diet  that  helps  to control seizures in some people with epilepsy. It is prescribed by a physician and carefully monitored by a dietitian. It is more strict, with calorie, fluid, and protein measurement and occasional restriction than the modified Atkins diet, which is also used today.

B. Vagus Nerve Stimulation

Vagus nerve stimulation (VNS) is designed to prevent seizures by sending regular, mild pulses of electrical energy to the brain via the vagus nerve. These pulses are supplied by a device something like a pacemaker.

C. Ayurvedic Treatment for Epilepsy:- (5)

In Ayurveda Epilepsy is known as Apasmara and the epileptic attacks are known as Akshpaka.

There are some herbs that are used in treatment of epilepsy. These are as following:

  1. Brahmi (Bacopa monnieri):-

a. It nourishes brain and helps in bringing coordination between nervous system and daily activity.

b. It acts as brain tonic.

c. It is also helpful in treatment of epilepsy, insomnia

d. It is helpful in all type of mood disorders. It is also helpful in relieving anxiety, stress and mental fatigue

2. Ashwagandha ( Withania somnifera)

It is best anxiolytic herb in Ayurveda.

a. It manages stress and anxiety.

b. It is nerve tonic, it has claiming effect on nerves.

c. It is very beneficial for the nervous system.

d. This  herb possesses  anti-inflammatory,  anti-stress,  immunomodulatory, antioxidant properties.

e. It is useful in increase mental and physical performance.

3. Jatamansi (Nardostachys jatamansi)

a. It is CNS relaxant.

b. It is best herb with tranquillizing effect on brain.

4. Tagar (Valeriana wallichii)

a. It helps to calming down nervous system.

b. It helps to relieve stress, depression and anxiety which are the underlying causes of epilepsy.

5. Shankhpushpi (Convolvulus pluricaulis)

a. It has mild anti-epileptic/ anticonvulsant property.

b. It   help  to   reduce   stress,   depression,   anxiety,   dementia  which   are underlying causes of epilepsy.

D. Others

  1. Asan
  2. Yoga

XI. PHARMACOTHERAPY

Before  going to Pharmacotherapy, the following guidelines for drug therapy must kept in mind.

A. Guidelines for Drugs Therapy:-(10)

  1. Before commencement of drug therapy, attempt must be made to uncertain the cause of seizure . Some seizures are successfully treated surgically. The choice of drug depends on the benefit-risk ratio of the antiepileptic. The objective of therapy is to control seizures as completely possible,  without causing intolerable adverse reaction.
  2. Control should initially be attempted using a single drug therapy i:e monotherapy, choosen according to the type of epilepsy.The dose is increased until either the seizure cease or toxicity appear on combining antiepileptic drugs in most cases effect or additive.
  3. Anticonvulsant drug dosages must be individualized to avoid serious adverse reaction,  or inadequate control whenever possible,  plasma drug concentration must be monitored specially in patients on multiple drug therapy.
  4. All  changes  in  drug  therapy  should  be  made  as  gradually  as  possible, with only one change at any one time, changes in dosages may be required from time to time.

XII. ANTIEPILEPTIC DRUGS

Antiepileptic (also commonly known as Anticonvulsant drugs or as Antiseizure drugs) are a diverse group of pharmacological agents used in the treatment of epileptic seizures. Anticonvulsants are also increasingly being used in the treatment of bipolar disorder and borderline personality disorder,  since many seem to act as mood stabilizers, and for the treatment of neuropathic pain.  Anticonvulsants  suppress  the  excessive  rapid  firing  of neurons during seizures. Anticonvulsants also prevent the spread of the seizure within the brain. antiepileptic drugs may block sodium channels or enhance γ-aminobutyric acid (GABA) function. antiepileptic drugs reduce the release of excitatory glutamate, whose release is considered to be elevated in epilepsy, they also act on voltage gated calcium channel.

A. Classification of antiepileptic drug:-(9,10)

  • Anticonvulsant drug may be classified according to their chemical structure, they are given below.
  • Barbiturate: Eg: phenobarbital, mephobarbital, pentobarbital
  • Benzodiazepine: Eg: diazepam, clonazepam, nitrazepam
  • Hydantoin:- Eg: phenytoin, ethotoin, mephenytoin.
  • Succinimide:-Eg: ethosuximide, phensuximide, methsuximide.
  • Oxazlidinedione:- Eg: trimethadione, paramethadione.
  • Iminostilbine:- Eg: carbamazepine
  • Valproic acid derivative:-Eg: Valproic acid,   valproate sodium, divalproex sodium.
  • Chemically unrelated anticonvulsant:-Eg: acetazolamide, primidone.
  • Anticonvulsant drugs may be classified according to their mechanisms of action
  • Enhancement of GABA action:- Eg: phenobarbital, benzodiazepine
  • Inhibition      of           sodium  channel:-              Eg:         carbamazepine,   phenytoin, fosphenytoin, oxcarbazepine, lamotrigine
  • Inhibition of calcium channel:- Eg: ethosuximide, valproate, trimethadione.
  • Glutamate blockers:- Eg: felbamate, topiramate
  • GABA receptor agonist:- Eg: phenobarbital clonazepam, primidone
  • GABA transaminase inhibitors:- Eg: vigabatrin
  • GABA analogue:- Eg: gabapectin, pregabalin
  • Carbonic anhydrase inhibitors:- Eg: acetazolamide.

The main aim of antiepileptic drug is to inhibit abnormal neuronal discharge, the first three mechanisms are important.

Enhancement of GABA action: (19,12)

Gamma-Amino  Butyric  acid   (GABA)   is   an   amino   acid   which   acts   as a neurotransmitter in the central nervous system. It inhibits nerve transmission in the brain, calming nervous activity.

Phenobarbital: phenobarbital, also known as phenobarbitone or phenobarb, is a medication recommended by the World Health Organization for the treatment of certain types of epilepsy in developing countries. In the developed world it is commonly used to treat seizures in young children.

MoA: phenobarbital potentiate the effects GABA ( which is inhibitory neurotransmitters), by binding to GABA A receptor at different allosteric site as a result there is opening of chloride channel, due to which increased permeability of chloride ion/ increased influx of chloride ion into neuron which decreases excitability ( as a CNS depressant effect) by hyperpolarization of neuron.

Pharmacokinetic: Phenobarbital has an oral bioavailability of about 90%. Peak plasma concentrations are reached eight to 12 hours after oral administration. It is one of the longest-acting barbiturates , it remains in the body for a very long time (half-life of two to seven days) and has very low protein binding(20 to 45%). Phenobarbital is metabolized by the liver, mainly through hydroxylation and glucuronidation,   and   induces   many   isozymes   of the cytochrome P450 system.

Dose: For children: 1 to 3 mg/kg

For adult 50 to 100 mg 2 to 3 times daily. Drug interactions:

a. Anticoagulants

  • Phenobarbital lowers the plasma levels of dicumarol. Phenobarbital can induce hepatic  microsomal enzymes resulting  in   increased metabolism and decreased anticoagulant response of oral anticoagulants (e.g., warfarin, , dicumarol)

b. Corticosteroids

  • Phenobarbital appears to enhance the metabolism of exogenous corticosteroids probably through the induction of hepatic microsomal enzymes.

c. Griseofulvin

  • Phenobarbital appears to interfere with the absorption of orally administered griseofulvin, thus decreasing its blood level.

d. Doxycycline

  • Phenobarbital has been shown to shorten the half- life of doxycycline

E. Central nervous System  Depressants

  • The concomitant use of other central nervous system depressants including  other  sedatives  or  hypnotics, antihistamines,  tranquilizers,  or alcohol, may produce additive depressant effects.

F. Estradiol, estrone, progesterone and other steroidal hormones:

  • Pretreatment with or concurrent administration of phenobarbital may decrease the effect of estradiol by increasing its metabolism.

Uses:

  • Phenobarbital is used in the treatment of all types of seizures(except absence  seizures)  such  as,  temporal  lobe  epilepsy,  clonic  seizure, complex   partial   seizures,   refractory   seizures.,   tonic-clonic   seizure, secondary generalized seizures, simple partial seizures, tonic seizures.
  • Phenobarbital   is    the    first-line    choice    for    the    treatment   of neonatal seizures.
  • Phenobarbital                                      is                  sometimes                        used                    for alcohol detoxification and benzodiazepine detoxification for its sedative and anticonvulsant properties.
  • Phenobarbital is a cytochrome P450 inducer, and is used to reduce the toxicity of some drugs

Side   effects:   Common   side   effects   of   phenobarbital   includes,   dizziness, drowsiness, confusion, depression, headache, nausea, vomiting, loss of appetite, weakness, aggression, problems with memory, constipation.

Benzodiazepine:  Benzodiazepines (BZD, BZs), sometimes called "benzos", are a class of psychoactive drugs whose core chemical structure is the fusion of       a benzene ring and a diazepam ring. Benzodiazepines enhance the effect of the neurotransmitter gamma-aminobutyric  acid(GABA)  at  the GABAA receptor, resultingin sedative, hypnotic (sleep-inducing), anxiolytic(anti-anxiety), anticonvulsant, and muscle relaxant properties.

MOA Benzodiazepines work by increasing the efficiency of a natural brain chemical, GABA,  to  decrease  the  excitability  of neurons.  This  reduces  the communication between neurons and, therefore, has a calming effect on many of the functions of the brain.

Pharmacokinetic: Clonazepam is rapidly and completely absorbed after oral administration. The absolute bioavailability of Clonazepam is about 90%. Maximum plasma concentrations of Clonazepam are reached within 1 to 4 hours after oral administration. Clonazepam is approximately 85% bound to plasma proteins. Clonazepam is highly metabolized, with less than 2% unchanged Clonazepam being excreted in the urine. Biotransformation occurs mainly by reduction of the 7-nitro group to the 4-amino derivative. This derivative can be acetylated,   hydroxylated   and   glucuronidated.   Cytochrome   P-450,   including CYP3A, may play an important role in Clonazepam reduction and oxidation. The elimination half-life of Clonazepam is typically 30 to 40 hours.

Diazepam: diazepam are rapidly and completely absorbed after oral administration and it’s bioavailability is about 85%. These are also administered through IV and IM route , but onset of action is 1 to 5 min by IV and 15 to 30 min by IM route. These are metabolized in liver by glucuronidation. The biological half life is 15 to 20 hrs and shows long duration action about 10 to 20 hours. These are excreted through the kidney.

Uses: These are act as sedative and hypnotic for sleep disorders.

Benzodiazepine are used to control/ treat seizures eg clonazepam are used to treat myoclonic and absence seizure.

These are used to treat anxiety eg lorazepam. These are also act as muscle relaxant eg diazepam

These are used to treat insomnia and amnesia which are the underlying causes of epilepsy.

These are also used to treat panic disorder eg panic attack.

Side  effects:  drowsiness,  dizziness,  confusion,  blurred  vision  (nystagmus)  , agitation, headache, skin rash, hypotension, depression, impaired co-ordination, nausea, vomiting, inability to talk, coma, weakness.

Inhibition of sodium channel: (19,12)

Sodium currents are essential for the initiation and propagation of neuronal firing. Alterations of sodium currents can lead to abnormal neuronal activity, such as occurs in epilepsy. Within the central nervous system (CNS), VGSCs are critically important for regulating neuronal excitability, which are responsible for causing epilepsy. Influx of sodium ion through specific ion channels in the neuronal membrane causes a depolarization of neuron, which increases neuronal excitability.

Carbamazepine: Carbamazepine is a tricyclic compound chemically related to tricyclic antidepressants (TCA)  with  anticonvulsant  and  analgesic  properties. Carbamazepine is used to prevent and control seizures. This medication is known as an anticonvulsant or anti-epileptic drug. It is also used to relieve certain types of nerve pain (such as trigeminal neuralgia). This medication works by reducing the spread of seizure activity in the brain and restoring the normal balance of nerve activity.

MOA: These drug act on voltage-dependent sodium channel and prevent the entry of sodium ions into neuronal membrane which are necessary for the generation of action potential. OR These drug bind preferentially to sodium channel and stabilize the sodium ions prolong in inactive state, inhibit the high frequency repetitive firing in neuron. These drug also decrease the synaptic transmission and increase the inhibitory effect of GABA.

Pharmacokinetic: Carbamazepine is relatively slowly but well absorbed after oral administration. Its plasma half-life is about 30 hours when it is given as single dose,  but  it  is  a  strong  inducer  of  hepatic  enzymes  and  the  plasma  half-life shortens to about 15 hours when it is given repeatedly. CBZ is almost completely metabolized in the liver with only around 5% of the drug excreted unchanged. The major route of metabolism is conversion to CBZ 10.11-epoxide This reaction is primarily catalyzed by CYP3A4.

Uses: They are used to prevent and treat seizures

They are mostly used to treat generalized tonic-clonic seizure ( grand male epilepsy), partial seizure and psychomotor epilepsy.

They are used to treat nerve pain such as trigeminal neuralgia and diabetic neuropathy.

They are also used to treat bipolar disorder.

Side   effects:   Common side   effects may   include   drowsiness,   dizziness, headaches  and  migraines, motor  coordination impairment,  nausea,  vomiting, and/or constipation.

Phenytoin: Phenytoin (diphenylhydantoin) is a hydantoin compound related to the barbiturates that are used for the treatment of seizures. It is an effective anticonvulsant for the chronic treatment of tonic-clonic (grand mal) or partial seizures and the acute treatment of generalized status epilepticus.

MOA: phenytoin binds to a voltage-dependent sodium channel and prevent the high frequency repetitive firing of action potential. This can be done by prolong inactivation state of sodium channel. Each sodium channel dynamically exists in the following 3 states:

  • A resting state, during which the channel allows passage of sodium into the cell
  • An active state, in which the channel allows increased influx of sodium into the cell
  • An inactive state, in which the channel does not allow passage of sodium into the cell
  •  

Phenytoin that target the sodium channels prevent the return of these channels to  the  active  state  by  stabilizing  them  in  the  inactive  state  so,  they  prevent repetitive firing of the neuron.

Uses: Highly effective in

    • Tonic-clonic seizures
    • Partial seizures ( simple, complex)
    • Status epilepticus
    • Arrhythmia
    • Trigeminal neurologia

Common phenytoin side effects may include:

    • dizziness, drowsiness, confusion, nervousness
    • nausea, vomiting, constipation;
    • tremors, slurred speech, loss of balance or coordination;

Ethosuximide:

Ethosuximide is an succinimide based anticonvulsant commonly used for absence (petit mal) seizures in both adults and children.

MOA: ethosuximide decreases low-threshold T-type Ca2+currents in thalamic neurons,  and  has  no  effect  on  the  high  voltage-activated  Ca2+  currents. Ethosuximide reduces the peak amplitude of the low-threshold T-type Ca2+ current in the neurons of the thalamic ventrobasal complex, as well as in the reticular nucleus of the thalamus.

Pharmacokinetic:

  • completely absorbed by oral administration
  • Peak plasma concentrations is reached within 3 to 7 hours
  • Negligible protein binding
  • Completely metabolized in liver about 70 – 90%
  • Half life 40 hours.

Uses: Ethosuximide is a first choice of drug for treating absence seizures. It is considered as second choice in myoclonic and atonic seizures.

Side effects:

    • Central  nervous  system:     drowsiness,  mental  confusion,  headache, insomania ataxia.
    • Gastrointestinal:   nausea   vomiting   constipation   cramps,   dyspepsia, stomach pain loss of appetite weight loss swelling of tongue gum enlargement
    • Blood: agranulocytosis,  leukopenia, eosinophilia.

Glutamate blockers:(9)

Glutamate is a powerful excitatory neurotransmitter that is released by nerve cells in the brain. It is responsible for causing epilepsy ( excessive neuronal activity in the brain). So felbamate, topiramate , are the important drug to inhibit glutamate as neurotransmitters.

Felbamate:

These are the glutamate NMDA receptor blocker/ NMDA receptor antagonist which prevents binding of glutamate to N-methyl D aspartate receptor and inhibit abnormal neuronal activity.

Uses: effective against tonic-clonic seizure ( rarely)

Felbamate is also used to treat children with Lennox-Gastaut syndrome Side effects: aplastic anemia, hepatic failure, weight loss, GI irritation

GABA transaminase inhibitor: (12)

GABA transaminase is an enzyme which catalyzes the breakdown of GABA to succinic semialdehyde So it is important to block the action GABA transaminase and enhance action of GABA.

Vigabatrin:

Vigabatrin is an antiepileptic drug that inhibits the breakdown of γ-aminobutyric acid (GABA) by acting as a suicide inhibitor of  the enzyme GABA  transaminase (GABA-T).

OR vigabatrin prevent the catabolism of GABA by irreversibly inhibiting the enzyme GABA transaminase, but does not bind to a receptor.

Use: It is used for treatment of adult refractory Complex partial seizure. Good first choice for infantile spasm from tuberous sclerosis.

Side effects

    • Central  nervous  system: headache,  dizziness,  nervousness,  memory disturbance, insomania, confusion.
  • Gastrointestinal tract: headache nausea abdominal pain constipation dyspepsia.

Carbonic anhydrase inhibitors: Carbonic anhydrase inhibitors are a class of pharmaceuticals that suppress the activity of carbonic anhydrase. Clinically is used in treatment of glaucoma, epilepsy, neurological disorder and used as a diuretic.

Acetazolamide: acetazolamide inhibit carbonic anhydrase in the central nervous system to minimize the abnormal and excessive discharge from CNS neuron.

Common side effect include loss of appetite, vomiting, kidney stone, acidosis, liver problem.

Table no 4: Choice of proper antiepileptic drugs for specific type of seizures.

 

Type of seizure

 

First line drug

 

Second line drug

 

Partial seizure

 

Carbamazepine, phenytoin

 

Gabapectin, Pregabalin

 

Generalized           tonic-clonic seizure

 

Carbamazepine, Phenytoin, valproate

 

Lamotrigine, clonazepam, oxcarbamazepine,

 

Absence seizures

 

Ethosuximide, valproate

 

Acetazolamide, clobazam,

 

Myoclonic             /          atonic seizures

 

Valproate,                     sodium valproate, topiramate

 

Clonazepam

 

Tonic seizures

 

Phenobarbital

 

Gabapectin

Conclusion

The treatment of epilepsy has been transformed since the serendipitous discovery of phenobarbital in 1912, both in the spectrum of medication available and improved knowledge of how best to use AEDs. Improving access to specialist information, as provided by the PwSI epilepsy service in primary care, encouraging adherence to medication combined with a rational combination of AED and concomitant medication, minimising side- effects and addressing any modifiable risk factors and addressing psychosocial issues can serve to optimise care for the patients with epilepsy.

References

[1] A book of neuropharmacology by Sloviter RS, Bumanglag AV, 2012. [2] A textbook of pathophysiology by Dr. S. L Bodhankar & Dr. N. S Vyawahare, Nirali prakashan, 10th edition 2016, Page no 3.5. [3] A textbook of principle of pathophysiology by Dr. C. M Jangme, R. D Wadulkar, Dr. M. D Burande, Dr. B. N Poul, Nirali prakashan, 1st edition 2015, page no 178 [4] A textbook of principle of pathophysiology by Dr. C. M Jangme, R. D Wadulkar, Dr. M M. D Burande, Dr. B. N Poul, Nirali prakashan, 1st edition 2015, page no 178 [5] Ayurvedic treatment of epilepsy authored by S Vidhya 2012 [6] Basic and clinical pharmacology by Bertram G Katzumg, Susab B Masters, Anthony J Trevor, tata McGraw hill publication, 12th edition 2010 page no 403. [7] Complication and prognosis of epilepsy authored by Frank Drislane and reviewed by Thaddeus Walczk, in 2004. [8] Epilepsy and its complication by Gordon R, Kelley MN, review in 2002. [9] Essential of medical pharmacology by KD Tripathi, JP brothers publishers, 7th edition 2013, page no 411.

Copyright

Copyright © 2022 Vikas Govind Kotkar , Prof. Latif Bagwan , Dr. L. D. Hingane . This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

ijraset40688Vikas

Download Paper

Authors : Vikas Govind Kotkar

Paper Id : IJRASET40688

Publish Date : 2022-03-08

ISSN : 2321-9653

Publisher Name : IJRASET

DOI Link : Click Here

About Us

International Journal for Research in Applied Science and Engineering Technology (IJRASET) is an international peer reviewed, online journal published for the enhancement of research in various disciplines of Applied Science & Engineering Technologies.

Quick links
  • Privacy Policy
  • Refund & Cancellation Policy
  • Shipping Policy
  • Terms & Conditions
Quick links
  • Home
  • About us
  • Editorial Board
  • Impact Factor
  • Submit Paper
  • Current Issue
  • Special Issue
  • Pay Fee
  • Topics
Journals for publication of research paper | Research paper publishers | Paper publication sites | Best journal to publish research paper | Research paper publication sites | Journals for paper publication | Best international journal for paper publication | Best journals to publish papers in India | Journal paper publishing sites | International journal to publish research paper | Online paper publishing journal

© 2022, International Journal for Research in Applied Science and Engineering Technology All rights reserved. | Designed by EVG Software Solutions